UK Markets open in 2 hrs 54 mins
NIKKEI 225
29,642.69+21.70(+0.07%)HANG SENG
28,793.14-107.69(-0.37%)CRUDE OIL
63.37-0.09(-0.14%)
Jazz Pharmaceuticals plc (JAZZ)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
168.39+2.02 (+1.21%)
At close: 4:00PM EDT
| Previous close | 166.37 |
| Open | 167.72 |
| Bid | 161.02 x 800 |
| Ask | 170.00 x 800 |
| Day's range | 167.39 - 170.21 |
| 52-week range | 101.81 - 178.64 |
| Volume | 742,990 |
| Avg. volume | 742,491 |
| Market cap | 9.485B |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | 39.90 |
| EPS (TTM) | 4.22 |
| Earnings date | 03 May 2021 - 07 May 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 202.53 |
- Zacks
JAZZ's Xywav sNDA for Hypersomnia Gets FDA Priority Review
JAZZ focuses on expanding label of its recently approved sleep drug, Xywav - a low sodium-formulation of Xyrem.
- Zacks
Jazz's (JAZZ) Vyxeos Gets FDA Nod for Pediatric Leukemia
Jazz Pharmaceuticals (JAZZ) gets FDA approval for label expansion of its cancer drug, Vyxeos, in pediatric patients with newly-diagnosed therapy-related acute myeloid leukemia.
- Zacks
Why Is Jazz (JAZZ) Down 5.6% Since Last Earnings Report?
Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2021 Verizon Media. All rights reserved.
